Class / Patent application number | Description | Number of patent applications / Date published |
424535000 | Milk or colostrum (e.g., butter, whey, etc.) | 71 |
20080206353 | Formulations And Treatments For Trichology - a formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of | 08-28-2008 |
20080233202 | Fungicidal Compositions - The present invention relates to fungicidal compositions and particularly fungicidal compositions comprising anhydrous milk fat (AMF), soybean oil and/or coconut fat. The invention also relates to a fungicidal method employing a composition of the invention. The compositions and methods of the invention have applications in the management (prevention and control) of fungal growth in commercial and small scale crop production. | 09-25-2008 |
20080268065 | FUNCTIONAL FOOD FOR AMELIORATING ENGOGENOUS MELATONIN SECRETION RHYTHM AND FUNCTIONAL FOOD FOR AMELIORATING CIRCADIAN RHYTHM - The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm. The functional food for improving a circadian rhythm contains the agent for improving a circadian rhythm. | 10-30-2008 |
20090022810 | EmunoTM Bar, by Nutra-ShieldTM - The invention, Emuno Bar by NutraShield, is a nutraceutical food bar composed of all natural ingredients that are rich in antioxidants and fortified with the patented Formulation 100 (U.S. Pat. No. 6,667,063, B2). The invention is a dedicated delivery system for U.S. Pat. No. 6,667,063, B2 and designed to boost the human immune system. The Emuno Bar will be the only Dark Chocolate covered functional food bar containing the new revolutionary patented Formulation 100. | 01-22-2009 |
20090117198 | VISCERAL FAT ACCUMULATION INHIBITOR, AND AGENT FOR PROMOTING THE INCREASE IN AND/OR INHIBITING THE DECREASE IN BLOOD ADIPONECTIN LEVEL - Disclosed is: a visceral fat accumulation inhibitor or a beverage/food for inhibiting the accumulation of a visceral fat, which comprises a fat globule membrane component as an active ingredient; or a agent or beverage/food for promoting the increase in and/or inhibiting the decrease in the blood adiponectin level, which comprises a fat globule membrane component as an active ingredient. A fat globule membrane component can inhibit the accumulation of a visceral fat, and/or can promote the increase in or inhibit the decrease in the blood adiponectin level. | 05-07-2009 |
20090181103 | CHOLESTEROL-LOWERING DAIRY PRODUCTS AND METHODS FOR THEIR PREPARATION - The invention relates to a concentrated or dried milk product having cholesterol-lowering effects and to methods for preparing the same. Provided is a process for the preparation of a milk concentrate or milk powder having a cholesterol-lowering effect, comprising :—preparing a milk liquid;—preparing a fat fraction comprising at least one sterol; and—subjecting the milk liquid to an evaporation procedure, during which procedure the fat fraction is added to the milk liquid before, in or after the liquid collector of one or more effects of the evaporator. Also provided is the product obtainable thereby. | 07-16-2009 |
20090252812 | Use of Fermented Milk Product for Skin Treatment - The use of a fermented milk product comprising non-hydrolysed whey proteins which is substantially free of casein proteins for the purpose of improving skin firmness, by structuring collagen without promoting collagen synthesis, when topically applied to skin is provided. | 10-08-2009 |
20090274768 | FRAKTIONEN AUS MOLKEPERMEAT UND DEREN VERWENDUNG ZUR PRAVENTION UND THERAPIE DES TYP-2 DIABETES UND DES METABOLISCHEN SYNDROMS - Fractions of whey permeate, preferably made, of sweet whey permeate and more preferably of hydrolyzed or partially hydrolyze sweet whey permeate are provided, particularly for use in the production of pharmaceutical compositions, or of food, for the treatment, prophylaxis, or alleviation of glucose intolerance and insulin resistance, and thus of symptoms of the metabolic syndrome, type 2 diabetes, and complications in humans. | 11-05-2009 |
20090324732 | METHOD FOR THE PRODUCTION OF MILK OR MILK PRODUCTS WITH A HIGH PROPORTION OF MELATONIN - A method for the production of milk with increased melatonin content or a milk product made therefrom. The method comprises dividing the daily cycle of a female mammal into a daytime phase under a first light regime with a proportion of blue light and a night-time phase under a second light regime and milking the mammal at least once during the night-time phase in order to obtain milk with an increased melatonin content. For the second light regime there is used at least one light source which emits light in the wavelength range of 500 nm or above and substantially no light in the wavelength range below 500 nm. | 12-31-2009 |
20090324733 | Composition of Whey Growth Factor Extract for Reducing Muscle Inflammation - The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation. | 12-31-2009 |
20100021555 | Compositions containing high omega-3 and low saturated fatty acid levels - Food products and supplements comprising the essential unsaturated fatty acids EPA or DHA at high concentrations relative to other n-3 HUFAs and with relatively low levels of saturated fatty acids (myristic and palmitic acids) are provided. These compositions can be made in commercial quantities in a cost effective manner by culture of selected microorganisms. The food products and supplements are suited to human health needs which are unable to be met from fish oil origins. Also provided are EPA containing food products obtained from animals. | 01-28-2010 |
20100040698 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR FUNCTIONAL GASTROINTESTINAL DISORDERS - The present inventors conducted dedicated studies, and as a result discovered that propionic acid bacteria fermentation products have a preventive/therapeutic effect on functional gastrointestinal disorders in in vitro tests and tests using patients with irritable bowel syndrome, and completed the present invention. Specifically, the present inventors discovered, in in vitro tests, that the products have an effect of increasing the intestinal contraction frequency without changing the intestinal contractile force in a distal colon-specific manner. Moreover, effects of improving the defecation condition, general abdominal condition, and health-related QOL in patients with irritable bowel syndrome were also found. Furthermore, propionic acid bacteria fermentation products can be taken in large amounts. Therefore, the propionic acid bacteria fermentation products can be expected to have an effect of preventing/treating functional gastrointestinal disorders safely. | 02-18-2010 |
20100068293 | MILK INGREDIENT ENRICHED IN POLAR LIPIDS AND USES THEREOF - A milk ingredient is enriched in polar lipids, in particular in phospholipids and in sphingolipids, in which the percentage of phospholipids is greater than 10% by weight, relative to the weight of solids of the ingredient, and a method obtains the same starting from pasteurized cream and is used in food and/or pharmaceutical products. | 03-18-2010 |
20100086616 | BREAST MILK ETHANOL SCREENING SYSTEM AND METHOD - A test kit detects the presence of a target analyte in a fluid sample. In particular, the test kit includes reagents capable of detecting the target analyte of interest in breast milk. More particularly, the test kit is capable of detecting the presence of alcohol, caffeine, nicotine, drugs of abuse, therapeutic drugs, triglycerides, lactose, capsaicin, and gluten, for example, in breast milk. | 04-08-2010 |
20100119614 | PROCESS FOR THE MANUFACTURE OF A DAIRY-BASED ANTI-INFLAMMATORY COMPOSITION - The present invention relates to a process for the preparation of a composition used in the prophylaxis and treatment of psoriasis and other auto-immune inflammatory disorders. The composition may be comprised of TGF-β1, TGF-β2, and dairy derived proteins comprising a large proportion of -lactoglobulin. | 05-13-2010 |
20100151039 | SKIN MOISTURIZING AGENT FOR ORAL INTAKE AND FUNCTIONAL FOODS AND DRINKS - The present invention provides functional food and beverage that produce a skin moisturizing effect through oral intake, that is excellently safe, and that may be taken regularly. The invention also provides a skin moisturizer for oral intake to be used in the functional food and beverage, as well as use thereof. The present skin moisturizer for oral intake contains as an active component fermented milk whey obtained by fermentation of milk with | 06-17-2010 |
20100166877 | PROMOTER OF DIFFERENTIATION AND KERATINIZATION OF EPIDERMIC CELL AND FUNCTIONAL BEVERAGE/FOOD FOR PROMOTION OF KERATINIZATION OF EPIDERMIS - The invention provides functional food and beverage that produce, through oral intake, a promotive effect on normal epidermal keratinization, and an epidermal differentiation and keratinization promoter for use in such functional food and beverage. The epidermal differentiation and keratinization promoter of the present invention contains, as an active component, fermented milk whey obtained by fermentation of milk with bacteria including lactic acid bacteria, such as | 07-01-2010 |
20100196498 | Emulsion hydro therapy or milk therapy for treatment of psoriasis - It is an object of the Invention furnish a method for treatment of psoriasis at the human body for the purpose of healing this disease by way of bacteriophages. The treatment of the psoriasis patient is performed with a whole bath. The bath liquid comprises 95 percent water and 5 percent fresh milk or 100 percent fresh milk. The treatment temperature amounts to about 99 degrees Fahrenheit over the complete treatment time of 30 minutes. A glycerol ointments to be applied to the patient at the erythematous positions after termination of the bath. The treatment period is daily over 14 days. | 08-05-2010 |
20100209526 | Product comprising a combination of milk serum apoproteins and free fatty acids - The present invention relates to use of a milk apoprotein or a mixture thereof to prevent or treat microbial or viral infection of the human or animal body. It is believed that this is achieved by inhibiting adhesion of potential pathogens. More preferably, at least one milk apoprotein or a mixture thereof is administered, simultaneously or sequentially, with either or both of at least one free fatty acid or a mixture thereof or a monoglyceride thereof; and/or at least one organic acid or a salt or ester thereof or a mixture thereof. The active agent(s) may be delivered by means of a pharmaceutically acceptable delivery system which includes parenteral solutions, ointments, eye drops, nasal sprays, intravaginal devices, surgical dressings, medical foods or drinks, oral healthcare formulations and medicaments for mucosal applications. | 08-19-2010 |
20100215762 | EDIBLE COMPOSITION FOR TREATING CUTANEOUS SIGNS OF AGEING - This invention relates to the provision of an edible composition for the treatment of cutaneous signs of ageing, in particular those associated with loss of skin elasticity, wrinkles and sagging. Thus the inventive composition provides skin benefits selected from the group consisting of enhancing collagen deposition in the skin, reducing the appearance of wrinkles and reducing sagging. Thus the invention provides an edible composition for treating aged skin, the composition comprising:
| 08-26-2010 |
20100221359 | Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin - A dietary supplement for mammalian consumption, and particularly human consumption, for the purpose of stimulating the immune system, inhibiting infection and increasing tissue repair and healing. Comprising colostrum, lactoferrin, and with modified citrus pectin as an optional component, the dietary supplement is administered in mucosal delivery format a dosage form that promotes effective absorption through the lining of the oral cavity. | 09-02-2010 |
20100247670 | Red Grape Dry Composition and Health Tea - Disclosed is a dry composition prepared from red grape by natural fermentation that is, once brewed, steeped within hot water, tasteful to ingest as herb tea, and that complementary contains antioxidants, Catechin, Resveratrol, Tannin, Quercetin bearing anti-inflammatory and blood glucose lowering capacities; as well as a human skin rejuvenating natural product derived there from. | 09-30-2010 |
20100255114 | METABOLIC IMPRINTING - The present invention generally relates to the field of nutrition. In particular the present invention relates to infant nutrition in the post natal period and in early life, more particular during the age period of 6-36 months or during a part thereof One embodiment of the present invention is a kit of diet compositions for children during the age period of 6-36 months or during a part thereof, wherein the macronutrient content of the compositions is gradually changing in the form of a straight line from a composition that comprises about 40-50% energy from fat and about 40-49% energy from carbohydrates for children at the age of 6 months to a composition that comprises about 30-35% energy from fat and about 50-55% energy from carbohydrates for children at the age of 36 months, and its use to prevent obesity later in life. Another embodiment relates to a range of shclf-stablc baby food products having an optimal energy profile for meeting the nutritional needs of an infant at a specific stage of infant development. | 10-07-2010 |
20100297253 | TREATMENT OF DIABETES WITH MILK PROTEIN HYDROLYSATE - A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum. | 11-25-2010 |
20100303924 | Process for Producing A Beverage Comprising Cocoa Material with Enhanced Polyphenol Levels - Process for producing a beverage comprising a cocoa material having an enhanced level of polyphenols, the process comprising the steps of: (a) adding a base to an aqueous phase to adjust the pH to between about 6.5 and about 7.5, (b) mixing ingredients into the aqueous phase to give a dispersion, the ingredients including the cocoa material having an enhanced level of polyphenols, (c) performing a thermal treatment on the dispersion, comprising heating the dispersion to over about 85° C. for at least about 5 seconds, and (d) cooling the treated dispersion. A beverage obtainable by the process is also disclosed. | 12-02-2010 |
20110020461 | HYALURONATE AND COLOSTRUM COMPOSITIONS AND METHODS OF USING THE SAME - The present disclosure includes disclosure of various embodiments of composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum. In at least one embodiment, the hyaluronate comprises sodium hyaluronate, and the colostrum comprises bovine colostrum. In an exemplary method of reducing osteoblastic activity within a warm-blooded vertebrate, the method comprises the step of administering a composition comprising a therapeutically-effective amount of a hyaluronate and a therapeutically-effective amount of colostrum to the warm-blooded vertebrate. | 01-27-2011 |
20110123640 | NOVEL FERMENTED MILK PRODUCT AND USE THEREOF - Disclosed is a fermented milk product, which is useful for the promotion of good health. The fermented milk product is produced by fermenting a milk raw material with a combination of microorganisms consisting of (1) | 05-26-2011 |
20110129543 | Fermented plant extracts, methods of production and uses - The present application concerns plant extracts which have been fermented with kephir grains, methods of production of these extracts, a powder comprising these extracts and compositions comprising these extracts. Since these extracts have a high content of aglycone active principles, their biological activities are high and their applications are varied. | 06-02-2011 |
20110151016 | USE OF ANGIOGENIN OR ANGIOGENIN AGONISTS FOR TREATING DISEASES AND DISORDERS - The invention provides a method of treating a disorder characterised by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuro-protection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided. | 06-23-2011 |
20110171317 | METHOD FOR INHIBITING ACCUMULATION OF VISCERAL FAT - Disclosed is: a visceral fat accumulation inhibitor or a food or drink for inhibiting the accumulation of a visceral fat, which composes a fat globule membrane component as an active ingredient; or a agent or food or drink for promoting the increase in the blood adiponection level and/or inhibiting the decrease in the blood adiponection level, which composes a fat globule membrane component as an active ingredient. A fat globule membrane component can inhibit the accumulation of a visceral fat, and/or can promote the increase in or inhibit the decrease in the blood adiponection level. | 07-14-2011 |
20110195128 | TREATING OR PREVENTING GOUT - Use of glycomacropeptide to treat or prevent gout, use of one or more phospholipids and one or more gangliosides to treat or prevent gout, or use of glycomacropeptide and one or more phospholipids and one or more gangliosides to treat or prevent gout. | 08-11-2011 |
20110236500 | NUTRITIONAL SUPPLEMENT WITH COLOSTRUM AND EPA OR DHA OR GLA - The invention relates to a nutritional composition comprising colostrum and a fat blend that is particularly suited the treatment of intestinal dysfunction in HIV patients. | 09-29-2011 |
20110256233 | HUMAN MILK PERMEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease. | 10-20-2011 |
20110293735 | COMPOSITION OF PESTICIDE - A composition of pesticide is a composed of banana oil, pepper powder, urea, and milk powder. Banana oil is composed of ethyl acetate, n-butyl acetate, n-butanol, ketone, benzol, and xylene. Banana oil is diluted with water at a proper ratio. Pepper powder is added to banana oil to provide an excellent effect of pest killing. Urea is diluted with water at a proper ratio. Milk powder is added to urea to provide protection to plant leaves. With such a composition, a practical improvement of being environmentally conservative, toxicant free, and pollution free is realized. | 12-01-2011 |
20110300229 | TREATING OR PREVENTING ROTAVIRUS INFECTION - Use of one or more of conjugated linoleic acid (CLA), high CLA milk fat, or one or more bovine milk lipid compositions to treat or prevent rotavirus infection. | 12-08-2011 |
20120034308 | REDUCED-CHOLESTEROL DAIRY PRODUCT FOR USE AS A MEDICAMENT - A ruminant reduced-cholesterol dairy product is used as a medicament. | 02-09-2012 |
20120100222 | SKIN FUNCTION-IMPROVING COMPOSITION - A skin function-improving composition for oral ingestion, which contains a milk-fat globule membrane. The composition is inexpensive, is highly safe, can be ingested orally, and has an activity of improving the dry condition of the skin so as to moisturize the skin. In particular, the milk-fat globule membrane is obtained from buttermilk or a processed product thereof. In particular, the composition has an activity of reducing transepidermal water loss or an activity of suppressing epidermal thickness. The composition can be ingested in the form of a food or beverage. | 04-26-2012 |
20120100223 | LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF - Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the aforementioned for the prophylaxis and treatment of numerous diseases are disclosed. The compositions include omega-6 and omega-3 fatty acids where the ratio of the omega-6 to the omega-3 fatty acids and their amounts are controlled based on one or more factors including age of the subject, sex of the subject, diet of the subject, the body weight of the subject, medical conditions of the subject, and climate of the subject's living area. | 04-26-2012 |
20120100224 | Compositions Against Rotavirus Infection and Processes For Producing The Same - The present inventors discovered that microfiltration retentates of whey, and products obtained by treating whey using centrifugation and/or ammonium sulfate precipitation, have the activity of inhibiting rotavirus infection. | 04-26-2012 |
20120213858 | ANTI-REFLUX INFANT NUTRITION - An infant formula for preventing gastro-esophageal reflux is disclosed comprising whey protein and/or casein, a galactomannan thickener, and a fermented milk-derived product. | 08-23-2012 |
20120219633 | REMOVAL OF IMMUNOGLOBULINS AND LEUKOCYTES FROM BIOLOGICAL FLUIDS - Devices, systems, and methods for depleting fluids of immunoglobulins and leukocytes are disclosed. | 08-30-2012 |
20120244226 | TREATMENT COMPOSITION AND METHOD - The present invention relates to a medicament including a treatment composition in combination with at least one anti-inflammatory composition, characterised in that the treatment composition is extracted from whole milk, processed milk or milk derived substance, and wherein the treatment composition contains a cationic fraction which includes two or more components of the whole milk, processed milk or milk derived substance with an isoelectric point of or greater than substantially 6.8. | 09-27-2012 |
20130078313 | MILK DERIVED COMPOSITION AND USE TO ENHANCE MUSCLE MASS OR MUSCLE STRENGTH - The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as methods for supplementing the nutritional needs of individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to increase skeletal muscle strength. | 03-28-2013 |
20130095189 | COMPOSITION AND METHOD OF PHYTONUTRIENTS FOR METABOLIC PROGRAMMING EFFECTS - The present disclosure relates methods of promoting phase II enzyme gene expression in a pediatric subject, comprising administering to the subject a nutritional composition comprising an effective amount of a phytonutrient. The disclosure also relates to methods of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients. The disclosure further relates to a method of promoting phase II enzyme gene expression in a prenatal infant, comprising administering to a female pregnant with the prenatal infant an effective amount of a composition comprising phytonutrients. | 04-18-2013 |
20130195990 | COMPOSITION OF WHEY GROWTH FACTOR EXTRACT FOR REDUCING MUSCLE INFLAMMATION - The invention relates to the production of compositions containing milk products for use as a nutritional supplement. More specifically, it relates to compositions containing whey growth factor extract, as well as their use in methods for reducing muscle inflammation in individuals undertaking resistance exercise training. According to one aspect of the invention, there is provided the use of a composition comprising whey growth factor extract, isolated from a milk product by cation exchange chromatography, to reduce exercise-induced muscle inflammation. | 08-01-2013 |
20130280343 | Food Products Derived From Cannabinoid-Administered Livestock - A process, wherein food-producing livestock are administered cannabinoid receptor agonists, is used to induce physiological and/or behavioral effects in the livestock. Food products are then derived from the livestock. | 10-24-2013 |
20140017332 | MILK-BASED PRODUCT AND A METHOD FOR ITS PREPARATION - The invention relates to a whey protein product having a ratio of whey protein to casein in the range from about 25:75 to about less than 50:50, a total protein content of at least 20% on dry matter basis, and a protein content of about 2.5 to about 8% by weight, based on the weight of the product. The product has a favourable amino acid composition and is especially suitable for athletes. The invention also relates to a method for producing a whey protein product, using microfiltration and ultrafiltration. The whey protein product is composed of the ultrafiltration re-tentate and a casein-containing material at a ratio of whey protein to casein of about 20:80 to about less than 50:50 and a total protein content of at least about 20% on dry matter basis. | 01-16-2014 |
20140072648 | Camel Milk-Based Topical Pharmaceutical Composition - The present invention relates to a novel pharmaceutical composition with milk of immunized camelid, particularly | 03-13-2014 |
20140072649 | Immunized Camel Milk-Based Composition for the Treatment or Prevention of Gastrointestinal Infections - The present invention relates to a novel composition with milk of immunized camelid, particularly, ( | 03-13-2014 |
20140120173 | Novel milk-fermented product and use thereof - The present invention discloses a novel milk-fermented product comprising a group of peptides. The peptides are composed from no. | 05-01-2014 |
20140186456 | Tripartite Bioactive Composition Providing Anti-Oxidant and Anti-Inflammatory Effects with Immune System and Stem Cell Production Enhancement - The inventive tripartite composition is a combination of fucoidan, trans-resveratrol, and bovine colostrum in effective quantities, in the range of from 1:1.5:1.5 to 1:10:10 in weight percent. This composition provides antioxidant protection of cells against free radicals, strengthens the immune system, and enhances cellular function and stem cell population, thereby providing renewal and repair throughout the body. The inventive composition can be administered by capsules, but is preferably applied in liquid form to the oral cavity, such as by sublingual dropper or by intraoral spray. This sublingual, intraoral application method of administration provides maximum absorption, thus minimizing cost, avoiding inactive ingredients that are present in tablets and capsules, increasing consumer convenience, acid eliminating stomach irritation. | 07-03-2014 |
20140234433 | Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin - The invention provides topical compositions including vitamin A, colostrum (or extracts of colostrum with a high IGF content) with or without avian eggshell membrane, that stimulate the epidermis and dermis layers of the skin to treat skin aging. | 08-21-2014 |
20140242182 | FORMULATIONS THAT STABILIZE PROTEINS - In one aspect, the disclosure provides formulations that stabilize proteins, wherein the formulations comprise a buffer. In some embodiments, the buffer comprises potassium mono-hydrogen-phosphate and potassium di-hydrogen-phosphate, or the buffer comprises sodium mono-hydrogen-phosphate and sodium di-hydrogen-phosphate. In some embodiments, the protein is a therapeutic protein. In some embodiments, the therapeutic protein is antithrombin. | 08-28-2014 |
20140248370 | Enhancement Composition - An enhancement composition includes a combination of natural ingredients that form a synergy to enhance the health, appearance, smell, and psyche of a surface, such as skin. Unnatural or processed ingredients are not included that can cause irritation and more detrimental effects to the skin. The enhancement composition has no preservatives because the particular combination of elements in the cream disclosed herein preserves the cream and permits a long shelf life. The enhancement composition is fabricated by combining, mixing, and sometimes heating predetermined amounts of Frankincense, Myrrh, black seed, and aloe. Additional ingredients can include, Shea butter, camel hump butter, coconut oil, olive oil, ginseng, natural resins, fatty acids, and various oils. The ingredients are combined by mixing, heating, cooling, distilling, or applying radiation. The composition promotes of spiritual health, particularly when implemented to include Frankincense and Myrrh. | 09-04-2014 |
20140287056 | USE OF WHEY PROTEIN MICELLES FOR INFANTS AT RISK OF OBESITY OR DIABETES - The invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in insulin secretion and/or plasma IGF-1 concentration in an infant at risk of developing obesity or diabetes. The invention also relates to a nutritional composition for infants comprising whey protein micelles. Further, the invention relates to a non-therapeutic use of a nutritional composition for infants, comprising whey protein micelles. | 09-25-2014 |
20140287057 | DIETARY PRODUCT INTENDED FOR THE PREVENTION OF CARDIOMETABOLIC RISK - A dietary product for preventing cardiometabolic risk in humans, in particular for reducing visceral fat and deep subcutaneous fat, includes in particular a mixture of: a whey hydrolysate having a molecular weight of between 200 and 10,000 daltons, an isolate and/or concentrate of whey, and calcium caseinate. | 09-25-2014 |
20140328938 | Pharmaceutical Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol - Biodegradable pharmaceutical compositions comprising 1,3-propanediol and its esters are provided. The 1,3-propanediol and its esters in the pharmaceutical composition are biologically derived, and as such, the pharmaceutical compositions exhibit a low anthropogenic CO | 11-06-2014 |
20140335196 | FUNGICIDAL COMPOSITIONS - The present invention relates to fungicidal compositions and particularly fungicidal compositions comprising anhydrous milk fat (AMF), soybean oil and/or coconut fat. The invention also relates to a fungicidal method employing a composition of the invention. The compositions and methods of the invention have applications in the management (prevention and control) of fungal growth in commercial and small scale crop production. | 11-13-2014 |
20140342010 | USE OF FOTI TO ENHANCE STEM CELL MOBILIZATION AND PROLIFERATION - The present invention provides a method of using | 11-20-2014 |
20150030687 | Use of Fermented Milk Product for Skin Treatment - The use of a fermented milk product comprising non-hydrolysed whey proteins which is substantially free of casein proteins for the purpose of improving skin firmness, by structuring collagen without promoting collagen synthesis, when topically applied to skin is provided. | 01-29-2015 |
20150064271 | LACTOCOCCUS LACTIS STRAINS FOR THE PRODUCTION OF BIOACTIVE PEPTIDES HAVING ANTI-HYPERTENSIVE AND CHOLESTEROL-LOWERING EFFECTS | 03-05-2015 |
20150079195 | Diane's Manna - This medicine is used treat Cancer, Pain and Bipolar. It can be taken as food or as a potent medicine in therapeutic effective amounts and potencies. It treats Cancer, depression, psychosis, manic symptoms, fear, Attention deficit symptoms, illness symptoms, pain, right lip retardation and removes bumps on the necks within a week or two. It is interchangeable in the ingredients. It can be combined with Pharmaceutical drugs and ingredients. It decreases the need for narcotics, cancer drugs or mental health drugs. It is extremely strong or potent and can be made weak or make your little ADD or Bipolar kid normal. It just has a continual ability. It is very potent. | 03-19-2015 |
20150093446 | Exfoliating Body Scrub Composition - An exfoliating body scrub composition is made from natural ingredients. The body scrub composition comprises ground coffee; ground whole oats; dry milk; from about 0.5% by weight to about 5% by weight of soy flour, based on the total weight of the coffee; oats; dry milk; and soy flour. The body scrub composition further comprises an optional carrier, such as an aqueous carrier, a moisturizing nonaqueous carrier, or a solid carrier. The body scrub composition may be made by combining solid ingredients comprising ground coffee, ground whole oats, dry milk, and from about 0.5% by weight to about 5% by weight of soy flour; and mixing the solid ingredients to produce a uniform powdered mixture. The uniform powdered mixture is optionally mixed with a carrier. | 04-02-2015 |
20150104523 | THERAPEUTIC COMPOSITIONS AND METHODS FOR ADDRESSING PHYSIOLOGICAL STRESSES AND AGING - Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed. | 04-16-2015 |
20150320878 | CURCUMIN-PEPTIDE CONJUGATES AND FORMULATIONS THEREOF - Disclosed here are compositions comprising a curcuminoid-peptide complex. Also disclosed are methods of preparing a curcuminoid-peptide complex, comprising obtaining a curcuminoid; obtaining a peptide; and mixing the curcuminoid and the peptide in a solvent. Also disclosed are methods of treating a subject, the method comprising identifying a subject in need of treatment of a curcumin-related disorder, and administering to the subject a therapeutic composition comprising a curcuminoid-peptide complex as described. Also disclosed are therapeutic compositions comprising a curcuminoid-peptide complex as described and a pharmaceutically acceptable excipient, diluent, or carrier. | 11-12-2015 |
20160082078 | LIQUID CONCENTRATED FORMULA - The invention pertains to a liquid complete nutritional composition suitable for feeding cachectic patients, having an energy density of at least 1.45 kcal/ml. The composition comprises a protein fraction in an amount of 7.8-12 g per 100 ml, a carbohydrate fraction, and a lipid fraction. At least 70 wt. % of the protein fraction can be obtained by demineralising milk, e.g. by ultrafiltration. The carbohydrate fraction (17-27 g per 100 ml) can comprise 0-35 wt. % of sucrose, 15-45 wt. % of other non-reducing mono-, di- and/or trisaccharides, especially trehalose, 5-50 wt. % of other mono- and disaccharides and 5-40 wt. % of tri- and higher saccharides. The product is suitably packaged in small volumes (10-150 ml). | 03-24-2016 |
20160089400 | FERMENTED NUTRITIONAL COMPOSITION WITH THIOL PROTEASE INHIBITOR - The present invention relates to fermentation of milk-derived nutritional compositions to increase thiol protease inhibitor activity, and uses thereof with the products obtained. | 03-31-2016 |
20160136225 | METHODS AND COMPOSITIONS FOR ENHANCING STEM CELL MOBILIZATION - The present invention provides a method of using mobilization agents to enhance stem cell mobilization in a subject, including hematopoietic stem cells (HSCs) and bone marrow stem cells (BMSCs). In one embodiment, a blended composition of fruits, mushrooms, microorganisms, maternal fluids, and extracts thereof are used to promote trafficking of stem cells, resulting in migration of the stem cells to specific sites of maintenance and repair within tissues and/or organs. Increased circulation of HSCs and/or BMSCs and migration towards sites of maintenance and the natural regeneration mechanisms in the body. Further provided is a dosing regimen for the administration of fucoidan and a method of enhancing release and circulation of stem cells. | 05-19-2016 |
20160158287 | NEW PROPHYLACTIC USE FOR PREVENTION OF INFECTIONS - The present invention concerns the field of nutritional compositions and concerns a nutritional composition, especially an infant formula containing whey protein/milk protein concentrate solids rich in phospholipids, rich in MFGM for use in the prophylaxis and prevention of infectious morbidity, especially otitis. At the same time the use of antipyretics has diminished. | 06-09-2016 |
20160158296 | LACTOCOCCUS LACTIS STRAINS FOR PRODUCING BIOACTIVE PEPTIDES HAVING ANTI-HYPERTENSIVE AND CHOLESTEROL-LOWERING EFFECTS | 06-09-2016 |
20160199784 | Separating and Demineralizing Biomolecule Solutions by Electrodialysis | 07-14-2016 |